BIO vs. CLSK
BIO (Bio-Rad Laboratories, Inc.) and CLSK (CleanSpark, Inc.) are both stocks. BIO operates in Medical Devices (Healthcare), while CLSK operates in Software - Application (Technology). Over the past 10 years, BIO returned 7.54%/yr vs -5.95%/yr for CLSK. At a 0.20 correlation, their price movements are largely independent.
Performance
BIO vs. CLSK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIO achieves a 1.48% return, which is significantly lower than CLSK's 65.81% return. Over the past 10 years, BIO has outperformed CLSK with an annualized return of 7.54%, while CLSK has yielded a comparatively lower -5.95% annualized return.
BIO
- 1D
- 0.87%
- 1M
- 19.58%
- YTD
- 1.48%
- 6M
- -3.93%
- 1Y
- 38.47%
- 3Y*
- -5.87%
- 5Y*
- -11.96%
- 10Y*
- 7.54%
CLSK
- 1D
- -4.71%
- 1M
- 25.13%
- YTD
- 65.81%
- 6M
- 11.64%
- 1Y
- 76.08%
- 3Y*
- 62.37%
- 5Y*
- 0.32%
- 10Y*
- -5.95%
BIO vs. CLSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 1.48% | -7.77% | 1.74% | -23.21% | -44.35% | 29.61% | 57.54% | 59.34% | -2.70% | 30.94% |
CLSK CleanSpark, Inc. | 65.81% | 9.88% | -16.50% | 440.69% | -78.57% | -67.23% | 442.99% | -73.90% | -15.98% | -30.29% |
Correlation
The correlation between BIO and CLSK is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2016 | 0.20 |
Fundamentals
BIO:
$6.24
CLSK:
-$2.24
BIO:
3.21
CLSK:
5.07
BIO:
$2.59B
CLSK:
$739.88M
BIO:
$1.34B
CLSK:
$306.93M
BIO:
$746.20M
CLSK:
-$103.41M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIO vs. CLSK — Risk / Return Rank
BIO
CLSK
BIO vs. CLSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and CleanSpark, Inc. (CLSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIO | CLSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.04 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.19 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.34 | 1.18 | +0.16 |
| Martin ratioReturn relative to average drawdown | 3.21 | 1.97 | +1.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BIO | CLSK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.94 | 0.87 | +0.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.32 | 0.00 | -0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.22 | -0.03 | +0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | -0.03 | +0.30 |
Drawdowns
BIO vs. CLSK - Drawdown Comparison
The maximum BIO drawdown since its inception was -83.64%, smaller than the maximum CLSK drawdown of -98.56%. Use the drawdown chart below to compare losses from any high point for BIO and CLSK.
Loading charts...
Drawdown Indicators
| BIO | CLSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.64% | -98.56% | +14.92% |
Max Drawdown (1Y)Largest decline over 1 year | -28.86% | -64.74% | +35.88% |
Max Drawdown (3Y)Largest decline over 3 years | -48.76% | -71.28% | +22.52% |
Max Drawdown (5Y)Largest decline over 5 years | -73.77% | -92.00% | +18.23% |
Max Drawdown (10Y)Largest decline over 10 years | -73.77% | -98.56% | +24.79% |
Current DrawdownCurrent decline from peak | -62.77% | -77.01% | +14.24% |
Average DrawdownAverage peak-to-trough decline | -27.73% | -69.49% | +41.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.01% | 38.67% | -26.66% |
Volatility
BIO vs. CLSK - Volatility Comparison
The current volatility for Bio-Rad Laboratories, Inc. (BIO) is 15.42%, while CleanSpark, Inc. (CLSK) has a volatility of 21.14%. This indicates that BIO experiences smaller price fluctuations and is considered to be less risky than CLSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIO | CLSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.42% | 21.14% | -5.72% |
Volatility (6M)Calculated over the trailing 6-month period | 28.42% | 62.43% | -34.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.99% | 88.30% | -47.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.27% | 100.73% | -63.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.01% | 183.19% | -149.18% |
Dividends
BIO vs. CLSK - Dividend Comparison
Neither BIO nor CLSK has paid dividends to shareholders.
Financials
BIO vs. CLSK - Financials Comparison
This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and CleanSpark, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BIO and CLSK have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLSK has higher volatility (21.14%) compared to BIO (15.42%). In terms of maximum drawdown, BIO dropped -83.64% vs CLSK's -98.56%.
BIO currently has the higher Sharpe Ratio (0.94 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIO and CLSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer